Abstract
Optical genome mapping is a high-resolution technology that can detect all types of structural variations in the genome. This second phase of a multisite study compares the performance of optical genome mapping and current standard-of-care methods for diagnostic testing of individuals with constitutional disorders, including neurodevelopmental impairments and congenital anomalies. Among the 627 analyses in phase 2, 405 were of retrospective samples supplied by five diagnostic centers in the United States and 94 were prospective samples collected over 18 months by two diagnostic centers (June 2021 to October 2022). Additional samples represented a family cohort to determine inheritance (n = 119) and controls (n = 9). Full concordance of results between optical genome mapping and one or more standard-of-care diagnostic tests was 98.6% (618/627), with partial concordance in an additional 1.1% (7/627).
Original language | English (US) |
---|---|
Pages (from-to) | 213-226 |
Number of pages | 14 |
Journal | Journal of Molecular Diagnostics |
Volume | 26 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2024 |
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Molecular Medicine